Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapy for thymoma

J D Cooper1

  • 1Department of Surgery, Washington University School of Medicine, Barnes Hospital, St. Louis, Mo.

Chest
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Thymomas, tumors of the anterior mediastinum, are classified by invasion and cell type. Prognosis for thymoma is linked to clinical stage, with radiotherapy showing potential benefit for malignant forms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal manifestations of CLN1 disease start during the early postnatal period.

Neuropathology and applied neurobiology·2020
Same author

CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease).

Scientific reports·2019
Same author

Desmopressin stimulation testing: Response to intravenous and intranasal forms.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Serum proteomic profiles of depressive subtypes.

Translational psychiatry·2016
Same author

Serum biomarkers predictive of depressive episodes in panic disorder.

Journal of psychiatric research·2015
Same author

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.

Translational psychiatry·2015
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
Same journal

Eisenmenger Syndrome: The Pulmonology Perspective.

Chest·2026
Same journal

Phenotyping of pulmonary arterial hypertension associated with congenital heart disease using latent class analysis: insights from a national prospective registry.

Chest·2026
Same journal

Septic Shock and GLP-1 Analogue Association in Real World - A Propensity Score Matched Analysis.

Chest·2026
Same journal

PREVALENCE AND RISK FACTORS OF PRESERVED RATIO IMPAIRED SPIROMETRY (PRISm) IN PEOPLE WITH HIV AND MATCHED POPULATION CONTROLS.

Chest·2026
See all related articles

Area of Science:

  • Oncology
  • Pathology

Background:

  • Thymomas are the most common anterior mediastinum neoplasms.
  • Thymic neoplasms are categorized into benign thymomas, malignant thymomas (invasive), and thymic carcinomas based on histology and behavior.
  • Microscopic analysis reveals thymomas composed of lymphocytic, epithelial, and fusiform cells, classified by predominant cell type or as mixed.

Purpose of the Study:

  • To provide an overview of thymic neoplasms, focusing on classification, prognosis, and treatment considerations.
  • To highlight the relationship between clinical stage and prognosis in thymomas.
  • To discuss the role of adjuvant therapies and the impact of associated myasthenia gravis.

Main Methods:

  • Histologic classification based on cellular features and capsular invasion.

Related Experiment Videos

  • Clinical staging for prognosis determination.
  • Review of treatment modalities including radiotherapy and chemotherapy.

    • Main Results:

    • Tumor behavior is determined by invasion: non-invasive are benign, invasive are malignant.
    • Thymic carcinomas exhibit histologically malignant epithelial features with poor prognosis.
    • Clinical stage is the primary prognostic factor; malignant thymomas generally respond to radiotherapy.
    • Myasthenia gravis does not worsen thymoma prognosis and can aid early diagnosis.
    • Cisplatin-based chemotherapy offers modest response rates in advanced thymic neoplasms.

    Conclusions:

    • Thymoma classification relies on invasion and cellular composition, with stage being critical for prognosis.
    • Radiotherapy is a viable treatment for malignant thymomas, while chemotherapy has a role in advanced cases.
    • Early diagnosis of thymoma can be facilitated by managing associated myasthenia gravis.